Urinary Tract Infections Therapy
Studies from University Nacional of Rosario update current data on urinary tract infections therapy
Published in Drug Law Weekly, December 26th, 2006
Data detailed in "Aryloxoalcanoic compounds induce resistance to antibiotic therapy in urinary tract infection caused by Escherichia coli" have been presented. "Clofibric acid (CL) is a compound used to control hypertriglyceridemia, and ethacrynic acid (ET) is administered to enhance diuresis. These compounds are structurally analogous to the herbicide 2,4-dichlorophenoxyacetic acid (2,4-D), as they have a chlorinated phenoxy moiety," scientists in Suipacha, Argentina report.
"As these agents are mainly excreted by the renal route, they could potentially coexist with Escherichia coli in the urinary tract of infected patients. Induction of the in vitro resistance...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
Source: Drug Law Weekly (2006-12-26)
More Articles from Drug Law Weekly
- Business & Finance
Inex receives positive court outcome for spin-out of Tekmira - Business Update
Tenet reaches partial settlement with IRS, expects to make $80 million payment in Q4 2006 - Collaborations
AstraZeneca signs distribution agreement with Par Pharmaceutical - Collaborations
BioTie, Roche sign agreement for vascular adhesion protein - Finance
Angiotech Pharmaceuticals proposes offering of senior floating rate notes due 2013 - Finance
Arena Pharmaceuticals announces public offering of common stock - More from this issue of Drug Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
